AC
OCEA

Ayrton Capital’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Ayrton Capital’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$52K Buy
+13,345
New +$61.3K 0.35% 21

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ayrton Capital's OCEA Position: Q3 2023 in Review

Ayrton Capital opened a new position in Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2023: 13,345 shares worth $52K. The stake represents 0.35% of the portfolio and ranks #21 among its holdings.

39 funds tracked by Wall St. Rank hold OCEA as of Q3 2023.

  • Ayrton Capital held 13,345 shares of Ocean Biomedical, Inc. Common Stock worth $52K as of Q3 2023.
  • Ocean Biomedical, Inc. Common Stock was a new Ayrton Capital position in Q3 2023.
  • Ocean Biomedical, Inc. Common Stock made up 0.35% of Ayrton Capital's portfolio in Q3 2023, its #21 holding.
  • 39 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2023.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.